Tag: Granulocyte colony stimulating factor

According to clinical guidelines, the timing of filgrastim administration relative to cytotoxic chemotherapy is a critical interaction to manage. A clear understanding of **what does filgrastim interact with** is essential for patients and healthcare providers to ensure the medication's effectiveness and avoid potential complications.

Neutrophils are the most common type of white blood cell, essential for fighting infection. So, what drug is used to increase neutrophils when counts fall to unsafe levels? The primary class of medications is called Granulocyte Colony-Stimulating Factors (G-CSFs).

NEUPOGEN (filgrastim) is a man-made form of a protein that stimulates the growth of white blood cells and is used to treat neutropenia. This powerful medication plays a critical role in preventing serious infections, a common and dangerous side effect of many cancer treatments. Understanding what is NEUPOGEN injection used for is crucial for patients undergoing certain medical procedures or living with chronic conditions that affect their immune system.

According to a meta-analysis, granulocyte colony-stimulating factors (G-CSFs) like filgrastim can reduce the incidence of febrile neutropenia by 46% in cancer patients. The primary purpose of filgrastim is to boost the body's production of infection-fighting white blood cells, specifically neutrophils, to mitigate the risk of severe infection, especially after cancer treatment.